Litcius/Paper detail

Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art

Pedro M. Veloso, Raúl Machado, Clarisse Nobre

2021European Journal of Pharmaceutics and Biopharmaceutics54 citationsDOI

Topics & Concepts

Inflammatory bowel diseaseMedicineIntensive care medicineDiseaseMesalazineDrug deliveryUlcerative colitisCrohn's diseaseInternal medicineNanotechnologyMaterials scienceInflammatory Bowel DiseasePregnancy and Medication ImpactMicroscopic Colitis
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art | Litcius